The narrative for cannabis in 2026 is defined by a massive shift in federal policy.
: Following a December 2025 executive order, the U.S. DOJ and DEA moved medical marijuana to Schedule III in April 2026. This reclassification acknowledges medical value and is expected to remove the "280E" tax burden, allowing companies to finally deduct standard business expenses. where do i buy marijuana stocks
: For years, U.S. companies were technically illegal at the federal level, leading to effective tax rates often exceeding 70%. The removal of 280E is the "solid story" for 2026, as it could instantly transform many cash-strapped operators into profitable ones. The narrative for cannabis in 2026 is defined